Form 8-K - Current report:
SEC Accession No. 0001213900-22-030570
Filing Date
2022-06-01
Accepted
2022-06-01 06:10:46
Documents
12
Period of Report
2022-05-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea160882-8k_abvcbio.htm   iXBRL 8-K 21480
  Complete submission text file 0001213900-22-030570.txt   186366

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20220527.xsd EX-101.SCH 3039
3 XBRL LABEL FILE abvc-20220527_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE abvc-20220527_pre.xml EX-101.PRE 22599
6 EXTRACTED XBRL INSTANCE DOCUMENT ea160882-8k_abvcbio_htm.xml XML 3174
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 22985893
SIC: 2834 Pharmaceutical Preparations